{"id":"https://openalex.org/W1980683385","doi":"https://doi.org/10.1016/j.breast.2011.08.016","title":"State of the Art Treatment of Triple Negative Breast Cancer","display_name":"State of the Art Treatment of Triple Negative Breast Cancer","publication_year":2011,"publication_date":"2011-10-01","ids":{"openalex":"https://openalex.org/W1980683385","doi":"https://doi.org/10.1016/j.breast.2011.08.016","mag":"1980683385"},"language":"en","primary_location":{"id":"doi:10.1016/j.breast.2011.08.016","doi":"https://doi.org/10.1016/j.breast.2011.08.016","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.breast.2011.08.016","pdf_url":"http://www.thebreastonline.com/article/S0960977611001834/pdf","source":{"id":"https://openalex.org/S181123643","display_name":"The Breast","issn_l":"0960-9776","issn":["0960-9776","1532-3080"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Breast","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.thebreastonline.com/article/S0960977611001834/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070245248","display_name":"Eric P. Winer","orcid":"https://orcid.org/0000-0002-8819-1723","observed_orcids":["https://orcid.org/0000-0002-8819-1723"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric P. Winer","raw_affiliation_strings":["Division of Women's Cancers, Dana-Farber Cancer Institute, Harvard Medical School, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Women's Cancers, Dana-Farber Cancer Institute, Harvard Medical School, USA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022319770","display_name":"NU Lin","orcid":"https://orcid.org/0000-0003-2263-5413","observed_orcids":["https://orcid.org/0000-0003-2263-5413"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nancy U. Lin","raw_affiliation_strings":["Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, USA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210161994"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3200,"currency":"USD","value_usd":3200},"apc_paid":{"value":3200,"currency":"USD","value_usd":3200},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.09639401,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"20","issue":null,"first_page":"S16","last_page":"S17"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11134","display_name":"Breast Lesions and Carcinomas","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/treatment","display_name":"treatment","score":0.4410000145435333},{"id":"https://openalex.org/keywords/tumor-heterogeneity","display_name":"tumor heterogeneity","score":0.6679999828338623},{"id":"https://openalex.org/keywords/genomic-instability","display_name":"genomic instability","score":0.6930000185966492},{"id":"https://openalex.org/keywords/egfr-overexpression","display_name":"EGFR overexpression","score":0.878000020980835},{"id":"https://openalex.org/keywords/basal-cytokeratins","display_name":"basal cytokeratins","score":0.9850000143051147},{"id":"https://openalex.org/keywords/estrogen-receptor","display_name":"estrogen receptor","score":0.6029999852180481},{"id":"https://openalex.org/keywords/progesterone-receptor","display_name":"progesterone receptor","score":1.0},{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.9290000200271606},{"id":"https://openalex.org/keywords/immunohistochemistry","display_name":"immunohistochemistry","score":0.8069999814033508}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9375622272491455},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.8494338393211365},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6781085729598999},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6208412051200867},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5727358460426331},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.5630633234977722},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5065442323684692},{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.5012032985687256},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4749871790409088},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.45114561915397644},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43093112111091614},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.4158937931060791},{"id":"https://openalex.org/C98717036","wikidata":"https://www.wikidata.org/wiki/Q14872994","display_name":"Progesterone receptor","level":5,"score":0.4125555753707886}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.breast.2011.08.016","doi":"https://doi.org/10.1016/j.breast.2011.08.016","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.breast.2011.08.016","pdf_url":"http://www.thebreastonline.com/article/S0960977611001834/pdf","source":{"id":"https://openalex.org/S181123643","display_name":"The Breast","issn_l":"0960-9776","issn":["0960-9776","1532-3080"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Breast","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.breast.2011.08.016","doi":"https://doi.org/10.1016/j.breast.2011.08.016","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.breast.2011.08.016","pdf_url":"http://www.thebreastonline.com/article/S0960977611001834/pdf","source":{"id":"https://openalex.org/S181123643","display_name":"The Breast","issn_l":"0960-9776","issn":["0960-9776","1532-3080"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Breast","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1980683385.pdf","grobid_xml":"https://content.openalex.org/works/W1980683385.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2497974553","https://openalex.org/W3029285160","https://openalex.org/W3083202708","https://openalex.org/W1985044550","https://openalex.org/W1999494609","https://openalex.org/W2052422202","https://openalex.org/W2770327728","https://openalex.org/W2393352232","https://openalex.org/W2793558092","https://openalex.org/W2494481908"],"abstract_inverted_index":{"Triple":[0],"Negative":[1],"Breast":[2],"Cancer":[3],"(TNBC)":[4],"is":[5,22,27,33,52,57,64],"characterized":[6,28],"by":[7,29],"negative":[8,17],"staining":[9],"for":[10,19],"estrogen":[11],"and":[12,15,26,48],"progesterone":[13],"receptors":[14],"a":[16,37,59],"assay":[18],"HER2.":[20],"TNBC":[21,56],"typically":[23],"high":[24],"grade":[25],"genomic":[30],"instability.":[31],"It":[32,51],"commonly":[34],"associated":[35],"with":[36],"variety":[38],"of":[39,46],"other":[40],"immunohistochemical":[41],"features":[42],"such":[43],"as":[44,71],"overexpression":[45],"EGFR":[47],"basal":[49],"cytokeratins.":[50],"clear,":[53],"however,":[54],"that":[55],"not":[58],"single":[60],"disease":[61],"entity,":[62],"but":[63],"remarkably":[65],"heterogeneous.":[66],"However,":[67],"it":[68],"remains":[69],"uncertain":[70],"to":[72],"how":[73],"this":[74],"heterogeneity":[75],"should":[76],"affect":[77],"treatment":[78],"decisions.":[79]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2016-06-24T00:00:00"}